Cancer is not one disease, and there is no single treatment or price. India's accredited cancer centres offer the full modern toolkit — surgery, chemotherapy, radiotherapy, targeted and immune therapies, transplant and cell therapy — planned by a team of specialists, and typically at 50–80% less than Western costs. This page explains how it works, honestly, and where to start.
There is no such thing as a single "cancer treatment". A breast cancer, a leukaemia and a lung cancer are entirely different diseases, treated in entirely different ways. What they share is that good care starts with an accurate diagnosis and staging , and a plan built by a multidisciplinary tumour board — surgeons, medical and radiation oncologists, radiologists and pathologists deciding together on the best combination and order of treatments. 2
For that reason, the most valuable first step is often not treatment at all, but a second opinion on the diagnosis and the proposed plan. Getting that right shapes everything that follows — and can change the treatment, the cost and the outcome. We help arrange it before anyone travels.
Most treatment plans combine two or more of these. Which apply depends entirely on the cancer type and stage.
For the conditions we cover in depth — with cited evidence, outcomes and costs — see the dedicated pages, including bone marrow transplant , CAR-T cell therapy and brain tumour surgery .
It would be misleading to quote a single survival figure for "cancer". Outcome depends overwhelmingly on two things, which is why an accurate diagnosis matters so much.
The honest picture. Some cancers, caught early, are highly curable; others, or those found late, are treated to control the disease and extend and improve life rather than to cure. Anyone quoting you a single success rate for "cancer treatment in India" is over-simplifying. Your realistic outlook comes from an oncologist who has seen your diagnosis, staging and pathology — which is exactly what a second opinion provides. 1,2
Because plans differ so much, these are broad indicative ranges per treatment type — not a total, and not a quotation. Your real figure comes from a plan built around your diagnosis.
Indicative, not a quotation. A full course typically means several cycles or sessions, so totals depend on the plan. Targeted therapy, immunotherapy and CAR-T cost more because of the drugs involved, but remain well below Western prices. India generally costs 50–80% less than the USA or Europe. Your itemised estimate follows once we have your diagnosis and reports.
Getting the diagnosis and reports to an oncologist first is what makes everything else — the plan, the cost, the travel — accurate.
Cancer outcomes are best at accredited, high-volume centres with a genuine multidisciplinary team. These are the accredited centres in our network.
Gurgaon
Mumbai
Bengaluru
Senior Consultant
Apollo Hospital, Bangalore
Director
Medanta - The Medicity Hospital, Gurgaon
Consultant
CK Birla Hospital, Gurgaon
Chairman
It depends entirely on the cancer type, stage and plan, so a single figure would be misleading. Once an oncologist has your diagnosis and reports, we send an itemised estimate for the specific plan.
For cancer, almost always yes. A tumour-board review can confirm or refine the diagnosis and plan before you commit to travel or treatment — sometimes changing it significantly. 2
At accredited centres, yes — India offers modern surgery, radiotherapy, targeted and immune therapies, transplant and home-grown CAR-T cell therapy, at a fraction of Western prices.
It varies with the plan — a single surgery may need a couple of weeks, while radiotherapy or several chemotherapy cycles take longer. We map the whole journey and arrange follow-up near home.
Yes. Send the diagnosis and we route you to the right specialist and centre. For some conditions we have detailed pages — such as blood-cancer transplant and CAR-T therapy — with cited evidence and costs.
This overview avoids quoting survival figures for "cancer" as a whole, because outcome depends on type and stage. These sources support the principles above.
This page is a general overview for patients and their families and is not medical advice. Health Route is a facilitator, not a healthcare provider. Your diagnosis, treatment plan and prognosis are decisions for a treating oncology team who have reviewed your pathology and staging. We do not diagnose, treat, or guarantee any outcome.
Stage at diagnosis as a principal determinant of cancer survival.
Cancer staging (e.g. TNM / AJCC) is one of the strongest predictors of outcome; earlier-stage disease is generally associated with substantially better survival. Individual prognosis requires an oncologist's assessment.
Multidisciplinary tumour board as standard of care in oncology.
Coordinated multidisciplinary team (MDT/tumour board) planning is the accepted standard for cancer care and is associated with more guideline-concordant treatment decisions.
Cancer burden in India and access to modern therapy.
WHO/GLOBOCAN report roughly 1.4–1.6 million new cancer diagnoses in India per year; accredited centres provide surgery, radiotherapy, systemic therapy, transplant and domestically produced CAR-T therapy.
An oncologist reviews them and writes back after the treating team completes its review with a second opinion on the plan, which centre and specialist fit, and an itemised estimate for the specific treatment. No charge, and no obligation to travel.